[Effect of metabolic substances of oral Actinomyces on Candida albicans].
Actinomyces naeslundii, Actinomyces viscosus and Candida albicans are associated with root cavity. The aim of this study was to determine, in vitro, the effect produced by the metabolic substances elaborated by Actinomyces naeslundii and Actinomyces viscosus on Candida albicans. The strains were isolated of saliva. There were used the double plaque diffusion method (DPDM) and the method of radial diffusion (MRD). The effect of the time of incubation and of different concentrations of metabolic substances elaborated by Actinomyces naeslundii and Actinomyces viscosus on the kinetics of growth of C. albicans were studied. Later, the nature of the substances produced by the two strains of Actinomyces was determined. It was found that there was no inhibition of the growth of C. albicans by A. naeslundii and A. viscosus in the DPDM and the MRD. There was stimulation of the growth of C. albicans by the two strains of Actinomyces when the DPDM was used. In the MRD the results were negative. Metabolic substances produced by both species stimulated the growth of C. albicans in low concentrations but at high concentrations inhibition was observed. The best concentration of the stimulating factor, a protein substance stable to 70 degrees C, corresponds to a dilution of 1/80. The inhibition of the growth of C. albicans was produced by the decrease of the pH, the higher effect being obtained with the dilution 1/5. The metabolic substances produced by A. naeslundii and A. viscosus can have both inhibitory and stimulant effects on C. albicans, according to their concentration. These metabolic interactions would condition the proportion of C. albicans in the oral microbial ecosystems.
Cátedra de Microbiología y Parasitología, Facultad de Odontología, Universidad Nacional de Tucumán, San Miguel de Tucumán, Argentina. sannan@fo.unt.edu.ar
Susana
S
Gutiérrez de Annan
Laura
L
Benito de Cárdenas
D000190:Actinomyces / Q000302:isolation & purification / Q000378:metabolism*; D001685:Biological Factors / Q000096:biosynthesis / Q000494:pharmacology*; D002176:Candida albicans / Q000187:drug effects*; D006801:Humans; D012463:Saliva / Q000382:microbiology
D001685:Biological Factors